Roche Applied Science and the Foundation for Innovative New Diagnostics (Find) will explore development of projects in the area of in-vitro diagnostics (IVD) products for poverty-related diseases
Find and Roche Diagnostics agreed to evaluate several fields of collaboration of common interest, to evaluate possibilities for introduction of new diagnostic tools in the public health sector of high endemic countries.
Among other aspects of this collaboration, Find will be responsible for conducting studies for the technical product evaluation in relevant clinical settings in developing countries.
Roche will bring in its experience in development and service in diagnostics.
Roche is a leader in in-vitro diagnostics and through its wide range of innovative products has contributed to major medical advances in modern medicine.
As a leading public-private partnership in the area of diagnostics, Find's main objective is to adapt the most sophisticated technologies to the needs of underprivileged people in developing countries to better fight poverty-related diseases.
Find's disease portfolio currently includes tuberculosis, sleeping sickness, and - more recently - malaria.
"Roche is glad to cooperate with Find in this very important field of poverty-related diseases.
"As one of the leading healthcare companies in the world it is Roche's mission to support people with high-quality diagnostic products that fit for their specific needs," stated Manfred Baier, head of Roche Applied Science.
"We are very pleased and look forward to collaborating with Roche Diagnostics to evaluate possibilities for facilitation the medical needs in developing countries," said Find chief executive officer, Giorgio Roscigno.
"One of Find's principal roles is to serve as a bridge between the private and public sector, and we are hopeful that IVD tools that are efficient, user-friendly and affordable can significantly increase the quality of diagnosis in these regions."
